| Dr Andrew Rudin, DO | |
|
8300 Collier Blvd, Naples, FL 34114-3549 | |
| (239) 354-6000 | |
| Not Available |
| Full Name | Dr Andrew Rudin |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 8300 Collier Blvd, Naples, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265813497 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 295191 (New York) | Secondary |
| 207P00000X | Emergency Medicine | OS15871 (Florida) | Secondary |
| 207P00000X | Emergency Medicine | 05372 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Physicians Regional Medical Center - Pine Ridge | Naples, FL | Hospital |
| Doctors Hospital Of Sarasota | Sarasota, FL | Hospital |
| Tj Health Columbia | Columbia, KY | Hospital |
| Englewood Community Hospital | Englewood, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Emergency Medicine Specialists Llc | 7517267628 | 11 |
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
News Archive
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
The most common length of pregnancy in the United States is now 39 weeks, a week shorter than the traditional definition of a full-term pregnancy. This shift occurred between 1992 and 2002, according to a new analysis by the March of Dimes published this month in a special supplement of the journal "Seminars in Perinatology."
A promising line of attack against pancreatitis and pancreatic cancer is to be explored further at Cardiff University, thanks to substantial new funding from the Medical Research Council.
For breast cancer patients, surgery is often the first line of treatment. Following surgery, patients must deal not only with the healing process, but also with lasting after effects such as scarring, skin sensitivity and body asymmetry. A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women's physical comfort, confidence and sexuality.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
› Verified 2 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20041207001148 |
News Archive
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
The most common length of pregnancy in the United States is now 39 weeks, a week shorter than the traditional definition of a full-term pregnancy. This shift occurred between 1992 and 2002, according to a new analysis by the March of Dimes published this month in a special supplement of the journal "Seminars in Perinatology."
A promising line of attack against pancreatitis and pancreatic cancer is to be explored further at Cardiff University, thanks to substantial new funding from the Medical Research Council.
For breast cancer patients, surgery is often the first line of treatment. Following surgery, patients must deal not only with the healing process, but also with lasting after effects such as scarring, skin sensitivity and body asymmetry. A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women's physical comfort, confidence and sexuality.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
› Verified 2 days ago
| Entity Name | Paragon Emergency Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912101650 PECOS PAC ID: 8628153087 Enrollment ID: O20080310000143 |
News Archive
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
The most common length of pregnancy in the United States is now 39 weeks, a week shorter than the traditional definition of a full-term pregnancy. This shift occurred between 1992 and 2002, according to a new analysis by the March of Dimes published this month in a special supplement of the journal "Seminars in Perinatology."
A promising line of attack against pancreatitis and pancreatic cancer is to be explored further at Cardiff University, thanks to substantial new funding from the Medical Research Council.
For breast cancer patients, surgery is often the first line of treatment. Following surgery, patients must deal not only with the healing process, but also with lasting after effects such as scarring, skin sensitivity and body asymmetry. A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women's physical comfort, confidence and sexuality.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
› Verified 2 days ago
| Entity Name | Integrated Emergency Medicine Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174991632 PECOS PAC ID: 7517267628 Enrollment ID: O20151121000178 |
News Archive
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
The most common length of pregnancy in the United States is now 39 weeks, a week shorter than the traditional definition of a full-term pregnancy. This shift occurred between 1992 and 2002, according to a new analysis by the March of Dimes published this month in a special supplement of the journal "Seminars in Perinatology."
A promising line of attack against pancreatitis and pancreatic cancer is to be explored further at Cardiff University, thanks to substantial new funding from the Medical Research Council.
For breast cancer patients, surgery is often the first line of treatment. Following surgery, patients must deal not only with the healing process, but also with lasting after effects such as scarring, skin sensitivity and body asymmetry. A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women's physical comfort, confidence and sexuality.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
› Verified 2 days ago
| Entity Name | Emergency Medicine Services Of Fl Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043917180 PECOS PAC ID: 8426413931 Enrollment ID: O20230504001881 |
News Archive
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
The most common length of pregnancy in the United States is now 39 weeks, a week shorter than the traditional definition of a full-term pregnancy. This shift occurred between 1992 and 2002, according to a new analysis by the March of Dimes published this month in a special supplement of the journal "Seminars in Perinatology."
A promising line of attack against pancreatitis and pancreatic cancer is to be explored further at Cardiff University, thanks to substantial new funding from the Medical Research Council.
For breast cancer patients, surgery is often the first line of treatment. Following surgery, patients must deal not only with the healing process, but also with lasting after effects such as scarring, skin sensitivity and body asymmetry. A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women's physical comfort, confidence and sexuality.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Rudin, DO 8300 Collier Blvd, Naples, FL 34114-3549 Ph: (239) 354-6057 | Dr Andrew Rudin, DO 8300 Collier Blvd, Naples, FL 34114-3549 Ph: (239) 354-6000 |
News Archive
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
The most common length of pregnancy in the United States is now 39 weeks, a week shorter than the traditional definition of a full-term pregnancy. This shift occurred between 1992 and 2002, according to a new analysis by the March of Dimes published this month in a special supplement of the journal "Seminars in Perinatology."
A promising line of attack against pancreatitis and pancreatic cancer is to be explored further at Cardiff University, thanks to substantial new funding from the Medical Research Council.
For breast cancer patients, surgery is often the first line of treatment. Following surgery, patients must deal not only with the healing process, but also with lasting after effects such as scarring, skin sensitivity and body asymmetry. A new line of sleepwear now available to breast cancer survivors is the result of an ongoing research partnership between Ryerson University and Princess Margaret Hospital that examines how the side effects of surgery and treatment affect women's physical comfort, confidence and sexuality.
AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).
› Verified 2 days ago
John Wayne Sponaugle, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 7th St N, Naples, FL 34102 Phone: 239-436-5000 | |
Steven Michael Turbiner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 7th St N, Naples, FL 34102 Phone: 239-436-5000 | |
Dr. Dylan M Caldwell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Aviation Dr N Ste 9, Naples, FL 34104 Phone: 239-206-8885 Fax: 239-842-1213 | |
Dr. Jon E Lamos, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7955 Airport Pulling Rd N Ste 102, Naples, FL 34109 Phone: 239-593-3232 | |
Jack Derovanesian, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6400 Davis Blvd Ste 103, Naples, FL 34104 Phone: 239-775-2300 | |
Joseph John Violaris, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 7th St N, Naples, FL 34102 Phone: 239-624-2700 | |
Katherine Margaret Wietecha, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11190 Health Park Blvd, Naples, FL 34110 Phone: 239-610-4377 |